CoreWeave Stock Is Up Around 50% This Year, and Here's Why It Can Still Soar Higher

CoreWeave will be added to the Nasdaq-100 on June 22, a move that should trigger buying from index-tracking funds and improve investor visibility. The company’s revenue rose to more than $5.1 billion last year from $1.9 billion previously, but it also posted a $1.6 billion net loss over the trailing 12 months, keeping the stock in the high-risk category despite strong AI-driven demand.

Analysis

CRWV’s index inclusion is less about the headline and more about a forced-demand event into a relatively tight float. The first-order bid comes from passive replication, but the more durable effect is that options market makers and active growth funds will have to re-underwrite it as a core infrastructure name rather than a sponsor-backed AI beta trade, which can compress the risk premium if the stock holds through rebalancing.

The second-order winner is obviously NVDA: every incremental share of AI infrastructure spend that flows to specialized cloud capacity reinforces the chip scarcity narrative and keeps utilization high. The more interesting spillover is to NDAQ itself, because this kind of inclusion validates the index as a live asset-allocation product during a period when AI winners are increasingly being packaged via benchmark exposure rather than single-name conviction.

The risk is that the market is extrapolating flow into fundamentals. CRWV’s business still has an operating leverage problem: revenue can scale quickly, but if capex and financing costs rise faster than utilization, the market will eventually stop paying up for “growth at any cost.” That creates a binary setup over the next 1-3 months: if post-inclusion buying fades and the company doesn’t print a cleaner path to gross margin expansion, the stock can retrace sharply despite the index tailwind.

Consensus is likely underestimating how much of this move is mechanical and temporary. The better trade is not to chase the inclusion pop outright, but to own the beneficiaries with cleaner economics and use CRWV as a tactical event-driven name. The asymmetric setup is to fade strength after the rebalance window if implied volatility stays elevated, while staying long the chip supplier complex that monetizes the same AI capex cycle with less balance-sheet risk.

Key Decisions for Investors

• Tactically buy CRWV only into any post-rebalance dip over the next 2-4 weeks; size small and treat as an event-driven trade, not a core position. Risk/reward: attractive if passive/quant flows create a temporary dislocation, poor if you pay the inclusion premium.
• Overweight NVDA versus CRWV for 1-3 months: same AI-capex theme, but cleaner economics and better marginal pricing power. Use a relative-value long NVDA / short CRWV pair if you want exposure to the spending cycle without taking balance-sheet risk.
• Add NDAQ on any weakness over the next several sessions: the inclusion reinforces the franchise value of benchmark construction and index monetization, a slower but higher-quality beneficiary of the same flow dynamics.
• Consider short-dated CRWV put spreads after the inclusion date if IV remains elevated. Thesis: the forced-buy window is finite, and once it passes, the stock may reprice toward fundamentals rather than flow.
• Do not chase CRWV as a long-only compounder until the market gets evidence of margin stabilization over the next 1-2 earnings prints; without that, upside is flow-driven while downside remains fundamental.